• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

John Maraganore

Most influential entrepreneurs in biopharma
Special Reports

Most influential people in biopharma—the entrepreneurs

The leaders in this week's Most Influential People in Biopharma category have led companies of all types in this industry⁠—and they're still building today.
Eric Sagonowsky , Fraiser Kansteiner , Andrea Park , Annalee Armstrong , Kevin Dunleavy May 16, 2022 3:00am
cash  money

Alnylam founder Maraganore, successor Greenstreet get pay bumps

Apr 7, 2022 10:52am
John Maraganore casual

Alnylam founding CEO Maraganore steps down

Oct 28, 2021 11:05am
John Maraganore

Alnylam's CEO scored $7.8M—or $13.6M—in 2020. Who's counting?

Apr 15, 2021 11:34am
John Maraganore casual

Alnylam maps aggressive plan to catapult into biotech's top 5

Jan 11, 2021 12:39pm
alnylam

Alnylam nets FDA nod for Oxlumo, its 3rd rare disease drug

Nov 24, 2020 8:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings